Poland· PL-100255613

Vancomycin Kabi

A vancomycin product containing vancomycinum, registered in Poland by Fresenius Kabi Polska Sp. z o.o.. The same ATC class is registered in 11 of our 19 countries.

ATC J01XA01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedVancomycin KabiATCJ01XA01REGISTER NO.PL-100255613PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Vancomycin is registered in 11 of 19 countries.

Countries holding a registration under ATC J01XA01 (vancomycin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Vancomycin · ATC J01XA01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of vancomycin costs, country by country.

Normalised to the WHO defined daily dose (2 g), the median price runs from $0.068 in Finland to $96.70 in Switzerland — a ×1424 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Vancomycin · price per daily dose (2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$96.70
  • FI Finland$0.068
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Vancomycinum
Manufacturer
Fresenius Kabi Polska Sp. z o.o.
Country
Poland (PL)
ATC code
J01XA01
ATC class
Vancomycin
Defined daily dose
2 g, P
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991050191
  • gtin
    05909990906055

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

533 interactions on record for vancomycin.

Graded by severity as the source publishes them — 23 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Vancomycin · interactions on record

533 records

  • 23 severe
  • 99 moderate
  • 411 info

Most severe, free to view

  • PiperacillinJ01CA12severe
  • Piperacillin und Beta-Lactamase-InhibitorJ01CR05severe
  • CidofovirJ05AB12severe
  • Humane Immunglobuline, unspezifisch, extravaskulärJ06BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Vancomycin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vancomycin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Vancocin, Vancomycin Aptapharma
  • Belgium · Vancomycine Fresenius Kabi, Vancomycine Sandoz
  • Bulgaria · Vancocin Cp, Ванко-Вм
  • Cyprus · Vanco, Vanco Sapiens
  • Czechia · Cedepos, Edicin
  • Germany · Vanco-Saar, Vancomycin "lederle"
  • Denmark · Bactocin, Vancocin
  • Estonia · Vancomycin Kabi, Vancosan
  • Spain · Vancomicina Mip, Vancomicina Noridem
  • Finland · Vancomycin Bioglan, Vancomycin Bioglan 500 Mg Pulver Till Koncentrat Till Infusionsvätska, Lösning
  • France · Vancomycine Hikma, Vancomycine Kabi
  • United Kingdom (Northern Ireland) · Vancocin, Vancocin Matrigel
  • Greece · Lyovanco, Vancomycin Noridem
  • Croatia · Edicin, Vancomicin Viatris
  • Hungary · Vancocin, Vancomycin Aptapharma
  • Ireland · Vancocin, Vancocin Matrigel
  • Iceland · Vancomycin Fresenius Kabi, Vancomycin Hameln
  • Italy · Levovanox, Maxivanil
  • Lithuania · Vancomycin Ibe, Vancomycin Kabi
  • Luxembourg · Vancomycin Enterocaps, Vancomycine
  • Latvia · Vancomycin Kabi, Vancosan
  • Malta · Cedepos, Vancomycin Aptapharma
  • Netherlands · Vancocin Cp, Vancomycine Fresenius Kabi
  • Norway · Vancomycin Fresenius Kabi, Vancomycin Hameln
  • Portugal · Vancomicina Azevedos, Vancomicina Generis
  • Romania · Cedepos, Vancomicină Aptapharma
  • Sweden · Vancocin, Vancomycin Bioglan
  • Slovenia · Edicin, Vancomycin Viatris
  • Slovakia · Cedepos, Edicin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5b01340c-80ea-43fd-91ca-4821ae6ed0c3
GET /v1/drugs/5b01340c-80ea-43fd-91ca-4821ae6ed0c3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek do sporządzania koncentratu roztworu do infuzji",
  "source": "urpl",
  "strength": "1000 mg",
  "packaging": "05909991050191 ¦ Lz ¦ 21867\n10 fiol. 1000 mg proszku\n05909990906055 ¦ Lz ¦ 69610\n1 fiol. 1000 mg proszku",
  "substance": "Vancomycini hydrochloridum 1000 mg",
  "common_name": "Vancomycinum",
  "pl_product_id": "100255613",
  "pozwolenie_nr": "18691",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about vancomycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.